Ducommun is demonstrating a clear operational turnaround, with revenue accelerating to 11.0% year-over-year growth in 2026Q2 and gross margin expanding to 28.0%, the highest in the observed period. The company's free cash flow surged to $30.0M in 2026Q2, a 13....
Price trend, volume and key moving averages
Trailing total returns as of 10/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 6, 2026 | $1.18+20.2% vs $0.98 | $224M+4.7% vs $214M |
Q2 2026 May 12, 2026 | $0.75+10.6% vs $0.68 | $209M+4.7% vs $200M |
Q1 2026 Feb 26, 2026 | $1.05+15.4% vs $0.91 | $216M-0.7% vs $217M |
Q4 2025 Nov 6, 2025 | $0.99+4.2% vs $0.95 | $213M+0.3% vs $212M |
COSTA MESA, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) hosted its first Investor Day event in nearly four years.
Here is how Ducommun (DCO) and Lockheed Martin (LMT) have performed compared to their sector so far this year.
Ducommun remains a Buy as Vision 2032 targets 7-8% organic growth, a 23% EBITDA margin, and a larger Engineered Products mix. DCO's investment case now leans on defense and proprietary products, with commercial aerospace recovery and missile/radar programs driving incremental demand. Valuation upside depends on EV/EBITDA multiple expansion toward peers; the new price target is $216.50, reflecting improved estimates but lower sector multiples.
Ducommun Incorporated (DCO) Analyst/Investor Day Transcript
Benchmark DCO against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Ducommun Incorporated (DCO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $175.39 | $2.65B | -70.16 | 4.87% | -4.53% | -5.56% | — | |
| $43.07 | $8.08B | 331.31 | 18.52% | 2.03% | 1.14% | — | |
| $1090.38 | $60.99B | 33.99 | 11.22% | 21.28% | — | — | |
| $331.62 | $19.76B | 46.12 | 7.3% | 13.17% | 21.75% | — | |
| $274.95 | $7.12B | 23.81 | 19.18% | 24.39% | 19.97% | — | |
| $39.50 | $4.64B | -2.16 | 4.44% | -40.65% | — | — |
Ducommun Incorporated (DCO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Ducommun Incorporated (DCO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 6, 2026·SEC
May 12, 2026·SEC
May 4, 2026·SEC
Get notified when DCO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Ducommun Incorporated (DCO) stock FAQ — growth, dividends, profitability & financials explained
Ducommun Incorporated (DCO) reported $863.2M in revenue for fiscal year 2025. This represents a 629% increase from $118.4M in 1996.
Ducommun Incorporated (DCO) grew revenue by 4.9% over the past year. Growth has been modest.
Ducommun Incorporated (DCO) reported a net loss of $24.8M for fiscal year 2025.
Ducommun Incorporated (DCO) has a return on equity (ROE) of -5.6%. Negative ROE indicates the company is unprofitable.
Ducommun Incorporated (DCO) had negative free cash flow of $24.5M in fiscal year 2025, likely due to heavy capital investments.
